Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Oruka Therapeutics Insider Sold Shares Worth $706,735, According to a Recent SEC Filing

Oruka Therapeutics Insider Sold Shares Worth $706,735, According to a Recent SEC Filing

MT newswireMT newswire2026/10/21 08:03
04:03 AM EDT, 10/21/2026 (MT Newswires) -- Paul T Quinlan, General Counsel, on October 20, 2026, sold 9,000 shares in Oruka Therapeutics (ORKA) for $706,735. Following the Form 4 filing with the SEC, Quinlan has control over a total of 29,995 common shares of the company, with 29,995 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/907654/000090765426000110/xslF345X05/form4.xml
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!